StonvexLoading…
StonvexStonvexStonvexCore line items from SNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $62.51B | $58.45B | $57.56B | $62.34B |
Operating Income | $1.41B | $1.19B | $1.08B | $1.05B |
Net Income | $827.66M | $689.09M | $626.91M | $651.31M |
EPS (Diluted) | $9.95 | $7.95 | $6.70 | $6.77 |
Total Assets | $34.25B | $30.27B | $29.41B | $29.73B |
Total Liabilities | $25.80B | $22.24B | $21.23B | $21.71B |
Cash & Equivalents | $2.44B | $1.06B | $1.03B | $522.60M |
Free Cash Flow OCF − CapEx | $1.39B | $1.04B | $1.26B | $-114.89M |
Shares Outstanding | 82.43M | 85.87M | 92.85M | 95.51M |